Skip to main content
DNA Labs India

PALB2 Gene Pancreatic cancer type 3, susceptibility to NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PALB2 Gene Pancreatic cancer type 3, susceptibility to NGS Genetic Test

Short Name: PALB2 Gene Test

Also known as: PALB2 Gene Mutation Test, Pancreatic Cancer Genetic Susceptibility Test

PALB2 Gene Pancreatic cancer type 3, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify mutations in the PALB2 gene that increase susceptibility to pancreatic cancer type 3, enabling early risk assessment, genetic counseling, and personalized medical management to improve outcomes.

Test Code
2918
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No specific preparation required. Provide clinical history and undergo genetic counseling as per pre-test information.

Method: Venipuncture or finger-prick

Step 2

Laboratory Analysis

A blood sample will be collected via venipuncture or finger-prick. For FTA card, a single drop of blood is applied.

Step 3

Report Delivery

Apply pressure to the puncture site to prevent bleeding. Store sample as instructed for stability.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Understand the test purpose, provide informed consent, and share clinical and family history during genetic counseling.
2
During the Test:Blood sample collection is quick and minimally invasive, typically taking a few minutes.
3
After the Test:Results are available in 3-4 weeks. Follow up with a healthcare provider to discuss findings and next steps.

About This Test

Who Should Get This Test

The purpose of this test is to identify mutations in the PALB2 gene that increase susceptibility to pancreatic cancer type 3, enabling early risk assessment, genetic counseling, and personalized medical management to improve outcomes.

How to Prepare

  • Ensure patient identification and consent
  • Use sterile equipment for blood collection
  • Label samples correctly with patient details
  • Transport samples at ambient room temperature to the lab

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"This test is crucial for individuals with a family history of pancreatic cancer or related symptoms to assess genetic risk and guide early intervention strategies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume5 mL blood
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or finger-prick

Sample Stability

Blood samples: Stable for 48 hours at room temperature
Extracted DNA: Stable for years if stored properly
FTA card samples: Stable for extended periods at room temperature
Sample Rejection Criteria:
  • Hemolyzed or clotted blood samples
  • Insufficient sample volume
  • Incorrect labeling or missing patient information

Understanding Your Results

Results indicate the presence or absence of pathogenic mutations in the PALB2 gene. A positive result suggests increased genetic risk for pancreatic cancer type 3, while a negative result indicates no detected mutations, though risk may still exist due to other factors.
📊

Positive for PALB2 mutation

Increased susceptibility to pancreatic cancer type 3. Recommend enhanced screening, genetic counseling, and consultation with an oncologist for personalized management.

📊

Negative for PALB2 mutation

No pathogenic variant detected in the PALB2 gene. Risk may be lower, but clinical correlation and family history should be considered. Continue standard screening if indicated.

📊

Variant of uncertain significance (VUS)

Genetic variant detected but clinical significance unknown. Recommend periodic re-evaluation and genetic counseling for updated guidance.

⚠️ When to Consult a Doctor:

Consult a doctor if you have a family history of pancreatic cancer, experience symptoms like jaundice or weight loss, or receive a positive test result for further evaluation and management.

Limitations

  • Does not detect all genetic variants or mutations in other genes
  • Results may not predict cancer onset with certainty due to environmental factors
  • Limited to PALB2 gene; other pancreatic cancer susceptibility genes not covered

Risks & Considerations

  • Minimal risks from blood draw, such as bruising or infection
  • Psychological impact of genetic risk information
  • Potential for false positives or negatives, though rare with NGS

Interfering Factors

  • Sample contamination or degradation
  • Recent blood transfusions may affect DNA analysis
  • Inadequate sample volume or improper storage

Frequently Asked Questions

What is the PALB2 gene?
The PALB2 gene, or Partner and Localizer of BRCA2, is a tumor suppressor gene that helps repair damaged DNA. Mutations in this gene can increase the risk of cancers like pancreatic, breast, and ovarian cancer.
How is the PALB2 gene linked to pancreatic cancer type 3?
Studies show that mutations in the PALB2 gene impair DNA repair mechanisms, leading to a higher susceptibility to pancreatic cancer type 3, the most common form of pancreatic cancer.
Who should consider taking this genetic test?
Individuals with a family history of pancreatic cancer, personal history of related cancers, or symptoms such as jaundice, weight loss, or abdominal pain should consider this test for risk assessment.
How is the NGS genetic test performed?
The test uses Next Generation Sequencing (NGS) to analyze DNA from a blood or saliva sample. It sequences the PALB2 gene to detect mutations that may increase cancer risk.
What does a positive test result mean?
A positive result indicates a pathogenic mutation in the PALB2 gene, suggesting an increased genetic risk for pancreatic cancer type 3. It warrants further consultation with a healthcare provider for screening and management.
What are the symptoms of pancreatic cancer type 3?
Symptoms may include pain in the upper abdomen or back, loss of appetite, weight loss, fatigue, and jaundice (yellowing of skin and eyes). Early stages often show no symptoms.
Is the test covered by insurance?
Coverage varies by insurance plan. It is not typically covered under government schemes like PMJAY or CGHS. Check with your provider for specific details.
What is the cost of the PALB2 gene test?
The test costs INR 20000.0 at DNA Labs India, which includes sample collection, analysis, and a genetic counseling session.
How long does it take to get the test results?
Results are typically available within 3 to 4 weeks after sample collection. They can be accessed online, via email, or WhatsApp.
What preparation is needed before the test?
No fasting is required. Provide your clinical history and undergo a genetic counseling session to draw a family pedigree chart as part of pre-test information.
Are there any risks associated with the test?
Risks are minimal, such as bruising from blood draw. There may be psychological impacts from learning genetic risk, so genetic counseling is provided to support interpretation.
What should I do after receiving the test results?
Consult a healthcare provider, such as an oncologist or genetic counselor, to discuss results, understand implications, and plan for screening or preventive measures if needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.